- Home
- SANG vs RGC Comparison
SANG vs RGC Comparison
Compare SANG & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- RGC
- Stock Information
- Founded
- SANG 1984
- RGC 2014
- Country
- SANG Canada
- RGC Hong Kong
- Employees
- SANG N/A
- RGC N/A
- Industry
- SANG Computer Software: Programming Data Processing
- RGC Medicinal Chemicals and Botanical Products
- Sector
- SANG Technology
- RGC Health Care
- Exchange
- SANG Nasdaq
- RGC Nasdaq
- Market Cap
- SANG 235.6M
- RGC 105.3M
- IPO Year
- SANG 2021
- RGC 2021
- Fundamental
- Price
- SANG $7.01
- RGC $4.86
- Analyst Decision
- SANG
- RGC
- Analyst Count
- SANG 0
- RGC 0
- Target Price
- SANG N/A
- RGC N/A
- AVG Volume (30 Days)
- SANG 7.6K
- RGC 8.8K
- Earning Date
- SANG 02-06-2025
- RGC 10-25-2024
- Dividend Yield
- SANG N/A
- RGC N/A
- EPS Growth
- SANG N/A
- RGC N/A
- EPS
- SANG N/A
- RGC N/A
- Revenue
- SANG $244,406,000.00
- RGC N/A
- Revenue This Year
- SANG $3.36
- RGC N/A
- Revenue Next Year
- SANG $7.39
- RGC N/A
- P/E Ratio
- SANG N/A
- RGC N/A
- Revenue Growth
- SANG N/A
- RGC N/A
- 52 Week Low
- SANG $2.50
- RGC $3.03
- 52 Week High
- SANG $7.20
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- SANG 57.08
- RGC 44.96
- Support Level
- SANG $6.89
- RGC $4.75
- Resistance Level
- SANG $7.15
- RGC $5.21
- Average True Range (ATR)
- SANG 0.20
- RGC 0.30
- MACD
- SANG -0.02
- RGC 0.04
- Stochastic Oscillator
- SANG 51.28
- RGC 23.87
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.